Literature DB >> 7980893

Comprehensive management of bilateral acoustic neuromas. Current perspectives.

R J Briggs1, D E Brackmann, M E Baser, W E Hitselberger.   

Abstract

Bilateral acoustic neuromas are pathognomonic for neurofibromatosis 2. Patients with neurofibromatosis 2 present complex and challenging management problems, because growth or surgical removal of the acoustic neuroma may result in total hearing loss. Early diagnosis with gadolinium-enhanced magnetic resonance imaging and refinements in hearing preservation surgery have improved our ability to prevent total hearing loss. For patients with larger tumors or no useful hearing, the auditory brain-stem implant allows restoration of some auditory function when the tumor is removed. We describe our management strategy for patients with bilateral acoustic neuromas, and present case reports to show their diversity. We also discuss the newly identified neurofibromatosis 2 tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980893     DOI: 10.1001/archotol.1994.01880360007002

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  The neurosurgical aspects of neurofibromatosis 2: diagnosis and management.

Authors:  M Turgut; S Palaoğlu; O E Ozcan
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

2.  Retrosigmoid Craniotomy for Auditory Brainstem Implantation in Adult Patients with Neurofibromatosis Type 2.

Authors:  Sidharth V Puram; Barbara Herrmann; Fred G Barker; Daniel J Lee
Journal:  J Neurol Surg B Skull Base       Date:  2015-06-12

Review 3.  [Magnetic resonance imaging in patients with magnetic hearing implants: overview and procedural management].

Authors:  S Nospes; W Mann; A Keilmann
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

Review 4.  Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Authors:  John D Gettelfinger; John P Dahl
Journal:  J Pediatr Genet       Date:  2018-01-04

5.  Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges.

Authors:  Byung Sup Kim; Ho Jun Seol; Jung-Il Lee; Hyung Jin Shin; Kwan Park; Doo-Sik Kong; Do-Hyun Nam; Yang-Sun Cho
Journal:  Neurosurg Rev       Date:  2016-05-04       Impact factor: 3.042

6.  Opportunities and challenges for successful use of bevacizumab in pediatrics.

Authors:  Amy Barone; Joshua B Rubin
Journal:  Front Oncol       Date:  2013-04-29       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.